The Star Tribune profiles Pete McNerney, a Minnesota venture capitalist who is co-founder of a $375 million venture fund that invests in biotech, drug, and med-tech companies nationwide.
The portfolio of McNerney's firm, Thomas, McNerney & Partners, includes Torax Medical of Shoreview and Plymouth-based Atritech. Minnesota companies typically comprise about 20 to 25 percent of the fund's investments.
Read the Star Tribune article here.